Keros Therapeutics (KROS) Research & Development: 2019-2025
Historic Research & Development for Keros Therapeutics (KROS) over the last 7 years, with Sep 2025 value amounting to $19.5 million.
- Keros Therapeutics' Research & Development fell 60.35% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.4 million, marking a year-over-year decrease of 4.91%. This contributed to the annual value of $173.6 million for FY2024, which is 28.37% up from last year.
- Keros Therapeutics' Research & Development amounted to $19.5 million in Q3 2025, which was down 55.13% from $43.5 million recorded in Q2 2025.
- Keros Therapeutics' Research & Development's 5-year high stood at $49.2 million during Q3 2024, with a 5-year trough of $10.0 million in Q2 2021.
- Over the past 3 years, Keros Therapeutics' median Research & Development value was $38.3 million (recorded in 2024), while the average stood at $38.2 million.
- Per our database at Business Quant, Keros Therapeutics' Research & Development surged by 133.21% in 2022 and then slumped by 60.35% in 2025.
- Keros Therapeutics' Research & Development (Quarterly) stood at $18.8 million in 2021, then soared by 32.04% to $24.9 million in 2022, then soared by 50.77% to $37.5 million in 2023, then grew by 21.71% to $45.6 million in 2024, then plummeted by 60.35% to $19.5 million in 2025.
- Its last three reported values are $19.5 million in Q3 2025, $43.5 million for Q2 2025, and $48.7 million during Q1 2025.